Fundz

Neuro Sigma, Inc. reported raising $11.7 Million in an initial SEC Form D filing

PRIVATEAug 31, 2016

Amount Raised

$11.7 Million

$11.7 Million sold, per SEC Form D (first sale Aug 31, 2016)

Round Type

Venture

Los AngelesHealthcare

Quick answer

NeuroSigma, Inc. raised $11.7 Million in a funding round, dated August 31, 2016. NeuroSigma, Inc. is based in Los Angeles, California, United States.

How much did NeuroSigma, Inc. raise?
NeuroSigma, Inc. raised $11.7 Million in a funding round on August 31, 2016.
What does NeuroSigma, Inc. do?
NeuroSigma develops and commercializes trigeminal nerve stimulation (TNS) for a variety of neurologic and psychiatric disorders.
Where is NeuroSigma, Inc. based and how big is it?
NeuroSigma, Inc. is based in Los Angeles, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as NeuroSigma, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Zivo Bioscience raised $1.3M (Seed) on October 14, 2016.
  • EMMAUS LIFE SCIENCES, INC. raised $20M on October 14, 2016.
  • QT ULTRASOUND LLC raised $3M (Seed) on October 14, 2016.
  • Castle Creek Pharmaceuticals, LLC raised $48M on October 14, 2016.
  • IORA HEALTH, INC. raised $75M on October 13, 2016.
  • Feminina Group, Inc. raised $78K (Pre-Seed) on October 13, 2016.

Who to call at NeuroSigma, Inc., and when

A new round usually means NeuroSigma, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NeuroSigma, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NeuroSigma, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NeuroSigma, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NeuroSigma, Inc.

Location

10960 WILSHIRE BLVD.

Los Angeles, California, United States

About

NeuroSigma develops and commercializes trigeminal nerve stimulation (TNS) for a variety of neurologic and psychiatric disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NeuroSigma, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for NeuroSigma, Inc.'s next move

See what Strategic adds

NeuroSigma, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.